
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Germain Honvo, Raveendhara R. Bannuru, Olivier Bruyère, et al.
Drugs & Aging (2019) Vol. 36, Iss. S1, pp. 145-159
Open Access | Times Cited: 20
Germain Honvo, Raveendhara R. Bannuru, Olivier Bruyère, et al.
Drugs & Aging (2019) Vol. 36, Iss. S1, pp. 145-159
Open Access | Times Cited: 20
Showing 20 citing articles:
An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Olivier Bruyère, Germain Honvo, Nicola Veronese, et al.
Seminars in Arthritis and Rheumatism (2019) Vol. 49, Iss. 3, pp. 337-350
Open Access | Times Cited: 553
Olivier Bruyère, Germain Honvo, Nicola Veronese, et al.
Seminars in Arthritis and Rheumatism (2019) Vol. 49, Iss. 3, pp. 337-350
Open Access | Times Cited: 553
Evidence-Based Guideline for the management of osteoporosis in men
Nicholas R. Fuggle, Charlotte Beaudart, Olivier Bruyère, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 241-251
Open Access | Times Cited: 30
Nicholas R. Fuggle, Charlotte Beaudart, Olivier Bruyère, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 241-251
Open Access | Times Cited: 30
Osteoarthritis year in review 2020: epidemiology & therapy
George Peat, Martin J. Thomas
Osteoarthritis and Cartilage (2020) Vol. 29, Iss. 2, pp. 180-189
Open Access | Times Cited: 121
George Peat, Martin J. Thomas
Osteoarthritis and Cartilage (2020) Vol. 29, Iss. 2, pp. 180-189
Open Access | Times Cited: 121
Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of…
Aurélie Ladang, Charlotte Beaudart, Jean‐Yves Reginster, et al.
Calcified Tissue International (2023) Vol. 112, Iss. 2, pp. 197-217
Open Access | Times Cited: 39
Aurélie Ladang, Charlotte Beaudart, Jean‐Yves Reginster, et al.
Calcified Tissue International (2023) Vol. 112, Iss. 2, pp. 197-217
Open Access | Times Cited: 39
Recommendations for the optimal use of bone forming agents in osteoporosis
Nicola Veronese, Karine Briot, Núria Guañabens, et al.
Aging Clinical and Experimental Research (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 7
Nicola Veronese, Karine Briot, Núria Guañabens, et al.
Aging Clinical and Experimental Research (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 7
Role of Collagen Derivatives in Osteoarthritis and Cartilage Repair: A Systematic Scoping Review With Evidence Mapping
Germain Honvo, Laetitia Lengelé, Alexia Charles, et al.
Rheumatology and Therapy (2020) Vol. 7, Iss. 4, pp. 703-740
Open Access | Times Cited: 42
Germain Honvo, Laetitia Lengelé, Alexia Charles, et al.
Rheumatology and Therapy (2020) Vol. 7, Iss. 4, pp. 703-740
Open Access | Times Cited: 42
Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies
Germain Honvo, Laetitia Lengelé, Majed S. Alokail, et al.
Drugs (2025)
Closed Access
Germain Honvo, Laetitia Lengelé, Majed S. Alokail, et al.
Drugs (2025)
Closed Access
A Smaller Sample Size Is Associated With Lower Rates of Reporting of Harms in Randomized Controlled Trials Cited in the AAOS Clinical Practice Guidelines for Anterior Cruciate Ligament Injuries
Ryan D. Stadler, Ryan Terrany, Suleiman Y. Sudah, et al.
The American Journal of Sports Medicine (2025)
Closed Access
Ryan D. Stadler, Ryan Terrany, Suleiman Y. Sudah, et al.
The American Journal of Sports Medicine (2025)
Closed Access
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events
Evan Mayo‐Wilson, Nicole Fusco, Hwanhee Hong, et al.
Trials (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Evan Mayo‐Wilson, Nicole Fusco, Hwanhee Hong, et al.
Trials (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial
Lucio C. Rovati, Nadia Brambilla, Tomasz Blicharski, et al.
Osteoarthritis and Cartilage (2019) Vol. 28, Iss. 1, pp. 22-30
Open Access | Times Cited: 24
Lucio C. Rovati, Nadia Brambilla, Tomasz Blicharski, et al.
Osteoarthritis and Cartilage (2019) Vol. 28, Iss. 1, pp. 22-30
Open Access | Times Cited: 24
Research progress in arthritis treatment with the active components of Herba siegesbeckiae
Xiaoqian Lv, Xiaoyu Wang, Xuelei Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115939-115939
Open Access | Times Cited: 6
Xiaoqian Lv, Xiaoyu Wang, Xuelei Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115939-115939
Open Access | Times Cited: 6
Beyond Pharmacology: A Narrative Review of Alternative Therapies for Anxiety Disorders
Z Antoś, Klaudia Zackiewicz, Natalia Tomaszek, et al.
Diseases (2024) Vol. 12, Iss. 9, pp. 216-216
Open Access | Times Cited: 1
Z Antoś, Klaudia Zackiewicz, Natalia Tomaszek, et al.
Diseases (2024) Vol. 12, Iss. 9, pp. 216-216
Open Access | Times Cited: 1
Benefit–risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations
Bethea A. Kleykamp, Robert H. Dworkin, Dennis C. Turk, et al.
Pain (2021) Vol. 163, Iss. 6, pp. 1006-1018
Open Access | Times Cited: 8
Bethea A. Kleykamp, Robert H. Dworkin, Dennis C. Turk, et al.
Pain (2021) Vol. 163, Iss. 6, pp. 1006-1018
Open Access | Times Cited: 8
Liquid chromatography-mass spectrometry method for discovering the metabolic markers to reveal the potential therapeutic effects of naringin on osteoporosis
Yuanfeng Li, Jinyang Liu, Hongzheng Zhou, et al.
Journal of Chromatography B (2022) Vol. 1194, pp. 123170-123170
Closed Access | Times Cited: 5
Yuanfeng Li, Jinyang Liu, Hongzheng Zhou, et al.
Journal of Chromatography B (2022) Vol. 1194, pp. 123170-123170
Closed Access | Times Cited: 5
Basic-helix-loop-helix family member e41 suppresses osteoclastogenesis and abnormal bone resorption disease via NFATc1
Yufeng Zhang, Xiaoguang Li, Jianlong Lang, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109059-109059
Open Access
Yufeng Zhang, Xiaoguang Li, Jianlong Lang, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109059-109059
Open Access
Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms
Jean‐Yves Reginster, Olivier Bruyère, Philip G. Conaghan, et al.
Drugs & Aging (2019) Vol. 36, Iss. S1, pp. 3-6
Open Access | Times Cited: 2
Jean‐Yves Reginster, Olivier Bruyère, Philip G. Conaghan, et al.
Drugs & Aging (2019) Vol. 36, Iss. S1, pp. 3-6
Open Access | Times Cited: 2
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for nonsystematic adverse events
Evan Mayo‐Wilson, Nicole Fusco, Hwanhee Hong, et al.
Research Square (Research Square) (2019)
Open Access
Evan Mayo‐Wilson, Nicole Fusco, Hwanhee Hong, et al.
Research Square (Research Square) (2019)
Open Access
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for nonsystematic adverse events
Evan Mayo‐Wilson, Nicole Fusco, Hwanhee Hong, et al.
Research Square (Research Square) (2019)
Open Access
Evan Mayo‐Wilson, Nicole Fusco, Hwanhee Hong, et al.
Research Square (Research Square) (2019)
Open Access
The effectiveness of the use of non-drug treatment complexes and their impact on quality of life indicators, the psychosomatic status of patients with residual brucellosis with lesions of the musculoskeletal system
Н. В. Агранович, R. M. Muskhadzhieva, M S Sivolapova, et al.
Problems of Balneology Physiotherapy and Exercise Therapy (2022) Vol. 99, Iss. 5, pp. 28-28
Closed Access
Н. В. Агранович, R. M. Muskhadzhieva, M S Sivolapova, et al.
Problems of Balneology Physiotherapy and Exercise Therapy (2022) Vol. 99, Iss. 5, pp. 28-28
Closed Access
A Randomized Placebo-Controlled Trial of Efficacy and Safety: Drug-Free Gel Containing Ultra-Deformable Phospholipid Vesicles (TDT 064) in Osteoarthritic Knees
Varah Yuenyongviwat, Khanin Iamthanaporn, Pakjai Tuntarattanapong, et al.
Clinical Medicine Insights Arthritis and Musculoskeletal Disorders (2021) Vol. 14
Open Access
Varah Yuenyongviwat, Khanin Iamthanaporn, Pakjai Tuntarattanapong, et al.
Clinical Medicine Insights Arthritis and Musculoskeletal Disorders (2021) Vol. 14
Open Access